NCT01827540View on ClinicalTrials.gov

Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

HIV-infection/AIDS

Interventions

DRUG

Cenicriviroc

DRUG

Dolutegravir

DRUG

Midazolam

Trial Locations (1)

33126

SeaView Research, Inc., Miami

Sponsors

Collaborators (1)

ViiV Healthcare

All Listed Sponsors

collaborator

ViiV Healthcare

INDUSTRY

lead

Tobira Therapeutics, Inc.

INDUSTRY